CHARLES SCHWAB INVESTMENT MANAGEMENT INC - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 48 filers reported holding AVEO PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$18,000
-28.0%
28,6290.0%0.00%
Q3 2019$25,000
+25.0%
28,6290.0%0.00%
Q2 2019$20,000
-89.4%
28,629
-87.5%
0.00%
Q1 2019$189,000
-48.6%
229,6590.0%0.00%
Q4 2018$368,000
-49.1%
229,659
+5.3%
0.00%
Q3 2018$723,000
+46.7%
218,1290.0%0.00%
Q2 2018$493,000
+486.9%
218,129
+661.9%
0.00%
Q1 2018$84,000
+5.0%
28,6290.0%0.00%
Q4 2017$80,000
+433.3%
28,629
+89.6%
0.00%
Q2 2016$15,000
+7.1%
15,1000.0%0.00%
Q1 2016$14,000
-30.0%
15,1000.0%0.00%
Q4 2015$20,000
+5.3%
15,1000.0%0.00%
Q3 2015$19,000
-29.6%
15,1000.0%0.00%
Q2 2015$27,000
+22.7%
15,1000.0%0.00%
Q1 2015$22,000
+69.2%
15,1000.0%0.00%
Q4 2014$13,000
-23.5%
15,1000.0%0.00%
Q3 2014$17,000
-39.3%
15,1000.0%0.00%
Q2 2014$28,000
-76.7%
15,100
-81.1%
0.00%
Q1 2014$120,000
-18.9%
80,0000.0%0.00%
Q4 2013$148,000
-11.4%
80,0000.0%0.00%
Q3 2013$167,000
-37.2%
80,000
-22.9%
0.00%
-100.0%
Q2 2013$266,000103,7970.00%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Greylock XI GP Limited Partnership 584,004$1,068,000100.00%
GREAT POINT PARTNERS LLC 2,325,000$4,255,0001.89%
Sarissa Capital Management LP 2,570,759$4,704,0001.60%
Deer VI & Co. LLC 675,242$1,236,0000.68%
Palo Alto Investors LP 1,200,800$2,197,0000.16%
Baupost Group 3,829,350$7,008,0000.11%
Gruss Capital Management LP 533,253$976,0000.05%
Granahan Investment Management 676,451$1,238,0000.04%
Fore Research & Management, LP 674,200$1,233,0000.04%
TFS CAPITAL LLC 210,369$385,0000.03%
View complete list of AVEO PHARMACEUTICALS INC shareholders